TARS
Tarsus Pharmaceuticals, Inc.
Price:  
80.28 
USD
Volume:  
732,093.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TARS Fair Value

-189.46 %
Upside

What is the fair value of TARS?

As of 2026-11-14, the Fair Value of Tarsus Pharmaceuticals, Inc. (TARS) is -71.82 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 80.28 USD, the upside of Tarsus Pharmaceuticals, Inc. is -189.46%.

Is TARS a good investment?

With the market price of 80.28 USD and our fair value calculation, Tarsus Pharmaceuticals, Inc. (TARS) is not a good investment. Investing in TARS stocks now will result in a potential loss of 189.46%.

Note: valuation result may not be accurate due to the company's negative EPS.

80.28 USD
Stock Price
-71.82 USD
Fair Price
FAIR VALUE CALCULATION

TARS Fair Value

Peter Lynch's formula is:

TARS Fair Value
= Earnings Growth Rate x TTM EPS
TARS Fair Value
= 5.00 x -14.36
TARS Fair Value
= -71.82

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31 5Y Avg
Net income -13.83 -62.09 -135.89 -115.55 -66.42 -78.76
YoY growth 48.41% -348.95% -118.86% 14.97% 42.52% -72.38%

TARS Fair Value - Key Data

Market Cap (mil) 3,924.89
P/E
Forward P/E
EPS -14.36
Avg earnings growth rate -72.38%
TTM earnings -702.23